ClinConnect ClinConnect Logo
Search / Trial NCT06833606

Diagnosis and Outcomes of Placental Accretism

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 11, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Diagnosis

ClinConnect Summary

This clinical trial is looking at a condition called placenta accreta, which happens when the placenta attaches too deeply into the wall of the uterus. The main goal of the study is to see how well current methods can diagnose this condition and to understand the different management strategies that can be used when it is suspected. The researchers want to learn more about the possible complications for mothers during and after pregnancy, depending on how the condition is managed.

To participate in this study, women need to be between 18 and 44 years old and must be pregnant with a suspicion of placenta accreta. There aren’t any specific exclusions for this trial, so if you meet the age requirement and have been told you might have this condition, you could be eligible. If you decide to join, you’ll be contributing to important research that could help improve care for future patients with similar concerns.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 years and 44 years
  • Pregnant women with suspected placental accretism
  • Acquisition of informed consent form
  • Exclusion Criteria:
  • None

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Forlì, , Italy

Reggio Emilia, , Italy

Bologna, , Italy

Parma, , Italy

Cesena, Forlì Cesena, Italy

Forlì, Forlì Cesena, Italy

Modena, , Italy

Rimini, , Italy

Cesena, , Italy

Patients applied

0 patients applied

Trial Officials

Gianluigi Pilu, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported